Loading...
Keywords
Last Name
Institution
 Back to Details

Connection

Tarak Srivastava to Humans

This is a "connection" page, showing publications Tarak Srivastava has written about Humans.

 
Connection Strength
  
 
 
1.987
  
  1. Srivastava T, Garola RE, Zhou J, Boinpelly VC, Rezaiekhaligh MH, Joshi T, Jiang Y, Ebadi D, Sharma S, Sethna C, Staggs VS, Sharma R, Gipson DS, Hao W, Wang Y, Mariani LH, Hodgin JB, Rottapel R, Yoshitaka T, Ueki Y, Sharma M. Scaffold protein SH3BP2 signalosome is pivotal for immune activation in nephrotic syndrome. JCI Insight. 2024 Feb 08; 9(3).
    View in: PubMed
    Score: 0.099
  2. Srivastava T, Ju W, Milne GL, Rezaiekhaligh MH, Staggs VS, Alon US, Sharma R, Zhou J, El-Meanawy A, McCarthy ET, Savin VJ, Sharma M. Urinary prostaglandin E2 is a biomarker of early adaptive hyperfiltration in solitary functioning kidney. Prostaglandins Other Lipid Mediat. 2020 02; 146:106403.
    View in: PubMed
    Score: 0.074
  3. Srivastava T, Hariharan S, Alon US, McCarthy ET, Sharma R, El-Meanawy A, Savin VJ, Sharma M. Hyperfiltration-mediated Injury in the Remaining Kidney of a Transplant Donor. Transplantation. 2018 10; 102(10):1624-1635.
    View in: PubMed
    Score: 0.068
  4. Srivastava T, Jafri S, Truog WE, Sebestyen VanSickle J, Manimtim WM, Alon US. Successful Reversal of Furosemide-Induced Secondary Hyperparathyroidism With Cinacalcet. Pediatrics. 2017 Dec; 140(6).
    View in: PubMed
    Score: 0.064
  5. Alon US, Jarka D, Monachino PJ, Sebestyen VanSickle J, Srivastava T. Cinacalcet as an alternative to phosphate therapy in X-linked hypophosphataemic rickets. Clin Endocrinol (Oxf). 2017 07; 87(1):114-116.
    View in: PubMed
    Score: 0.062
  6. Srivastava T, Thiagarajan G, Alon US, Sharma R, El-Meanawy A, McCarthy ET, Savin VJ, Sharma M. Role of biomechanical forces in hyperfiltration-mediated glomerular injury in congenital anomalies of the kidney and urinary tract. Nephrol Dial Transplant. 2017 May 01; 32(5):759-765.
    View in: PubMed
    Score: 0.062
  7. Sharma M, Sharma R, McCarthy ET, Savin VJ, Srivastava T. Hyperfiltration-associated biomechanical forces in glomerular injury and response: Potential role for eicosanoids. Prostaglandins Other Lipid Mediat. 2017 09; 132:59-68.
    View in: PubMed
    Score: 0.060
  8. Srivastava T, Krudys J, Mardis NJ, Sebestyen-VanSickle J, Alon US. Cinacalcet as adjunctive therapy in pseudohypoparathyroidism type 1b. Pediatr Nephrol. 2016 May; 31(5):795-800.
    View in: PubMed
    Score: 0.056
  9. Srivastava T, Alon US. Cinacalcet as adjunctive therapy for hereditary 1,25-dihydroxyvitamin D-resistant rickets. J Bone Miner Res. 2013 May; 28(5):992-6.
    View in: PubMed
    Score: 0.047
  10. Srivastava T, Garg U, Ruiz M, Dai H, Alon US. Serum 25(OH)-vitamin D level in children: is there a need to change the reference range based on 2011 Institute of Medicine report? Clin Pediatr (Phila). 2013 Feb; 52(2):178-82.
    View in: PubMed
    Score: 0.042
  11. Srivastava T, Dai H, Haney CJ, Alon US. Serum 25-hydroxyvitamin D level and acute-phase reaction following initial intravenous bisphosphonate. J Bone Miner Res. 2011 Feb; 26(2):437-8.
    View in: PubMed
    Score: 0.040
  12. Srivastava T, Kats A, Martin TJ, Pompolo S, Alon US. Parathyroid-hormone-related protein-mediated hypercalcemia in benign congenital mesoblastic nephroma. Pediatr Nephrol. 2011 May; 26(5):799-803.
    View in: PubMed
    Score: 0.040
  13. Srivastava T, Winston MJ, Auron A, Alon US. Urine calcium/citrate ratio in children with hypercalciuric stones. Pediatr Res. 2009 Jul; 66(1):85-90.
    View in: PubMed
    Score: 0.036
  14. Schwaderer A, Srivastava T. Complications of hypercalciuria. Front Biosci (Elite Ed). 2009 06 01; 1(1):306-15.
    View in: PubMed
    Score: 0.036
  15. Srivastava T, Schwaderer A. Diagnosis and management of hypercalciuria in children. Curr Opin Pediatr. 2009 Apr; 21(2):214-9.
    View in: PubMed
    Score: 0.035
  16. Srivastava T, Haney CJ, Alon US. Atorvastatin may have no effect on acute phase reaction in children after intravenous bisphosphonate infusion. J Bone Miner Res. 2009 Feb; 24(2):334-7.
    View in: PubMed
    Score: 0.035
  17. Srivastava T, Alon US, Althahabi R, Garg U. Impact of standardization of creatinine methodology on the assessment of glomerular filtration rate in children. Pediatr Res. 2009 Jan; 65(1):113-6.
    View in: PubMed
    Score: 0.035
  18. Srivastava T, Alon US. Pathophysiology of hypercalciuria in children. Pediatr Nephrol. 2007 Oct; 22(10):1659-73.
    View in: PubMed
    Score: 0.031
  19. Srivastava T, Althahabi R, Garg U. Measurement of urea nitrogen and creatinine concentrations in peritoneal dialysate and other body fluids using the Vitros analyzer. Clin Biochem. 2007 Mar; 40(5-6):420-2.
    View in: PubMed
    Score: 0.030
  20. Srivastava T, Garg U, Chan YR, Alon US. Essentials of laboratory medicine for the nephrology clinician. Pediatr Nephrol. 2007 Feb; 22(2):170-82.
    View in: PubMed
    Score: 0.029
  21. Srivastava T, Garola RE, Singh HK. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children. Kidney Int. 2006 Aug; 70(3):529-35.
    View in: PubMed
    Score: 0.029
  22. Srivastava T, Garola RE, Kestila M, Tryggvason K, Ruotsalainen V, Sharma M, Savin VJ, Jalanko H, Warady BA. Recurrence of proteinuria following renal transplantation in congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol. 2006 May; 21(5):711-8.
    View in: PubMed
    Score: 0.028
  23. Srivastava T. Nondiabetic consequences of obesity on kidney. Pediatr Nephrol. 2006 Apr; 21(4):463-70.
    View in: PubMed
    Score: 0.028
  24. Srivastava T, Alon US. Urolithiasis in adolescent children. Adolesc Med Clin. 2005 Feb; 16(1):87-109.
    View in: PubMed
    Score: 0.026
  25. Srivastava T, Kainer G. Collection under paraffin is not necessary for stability of urine pH over 24 h. Pediatr Nephrol. 2004 Feb; 19(2):169-71.
    View in: PubMed
    Score: 0.024
  26. Srivastava T, Alon US. The role of bisphosphonates in diseases of childhood. Eur J Pediatr. 2003 Nov; 162(11):735-51.
    View in: PubMed
    Score: 0.024
  27. Riar S, Srivastava T, George R. Transition of Care in Children with Chronic Kidney Disease, Dialysis, and Transplantation. Indian J Pediatr. 2023 Dec; 90(12):1237-1244.
    View in: PubMed
    Score: 0.024
  28. Hingorani S, Gibson KL, Xie Y, Wang Y, Eddy S, Hartman J, Sampson M, Cassol C, Thomas D, Gipson DS, Trachtman H, Srivastava T, Reidy K. The association of low birthweight and prematurity on outcomes in children and adults with nephrotic syndrome-a NEPTUNE cohort study. Pediatr Nephrol. 2023 10; 38(10):3297-3308.
    View in: PubMed
    Score: 0.023
  29. Srivastava T, Garola RE, Whiting JM, Alon US. Cell-cycle regulatory proteins in podocyte cell in idiopathic nephrotic syndrome of childhood. Kidney Int. 2003 Apr; 63(4):1374-81.
    View in: PubMed
    Score: 0.023
  30. Wang L, Smith-Salzberg B, Meyers KE, Glenn DA, Tuttle KR, Derebail VK, Brady TM, Gibson K, Smith AR, O'Shaughnessy MM, Srivastava T, Hall G, Zee J, Bitzer M, Sethna CB. Tobacco exposure in adults and children with proteinuric glomerulopathies: a NEPTUNE cohort study. BMC Nephrol. 2023 02 09; 24(1):30.
    View in: PubMed
    Score: 0.023
  31. Kallash M, Wang Y, Smith A, Trachtman H, Gbadegesin R, Nester C, Canetta P, Wang C, Hunley TE, Sperati CJ, Selewski D, Ayoub I, Srivastava T, Mottl AK, Kopp J, Gillespie B, Robinson B, Chen D, Steinke J, Twombley K, Reidy K, Mucha K, Greenbaum LA, Blazius B, Helmuth M, Yonatan P, Parekh RS, Hogan S, Royal V, D'Agati V, Chishti A, Falk R, Gharavi A, Holzman L, Klein J, Smoyer W, Kretzler M, Gipson D, Kidd JM. Rapid Progression of Focal Segmental Glomerulosclerosis in Patients with High-Risk APOL1 Genotypes. Clin J Am Soc Nephrol. 2023 03 01; 18(3):344-355.
    View in: PubMed
    Score: 0.023
  32. Chen DP, Helmuth ME, Smith AR, Canetta PA, Ayoub I, Mucha K, Kallash M, Kopp JB, Gbadegesin R, Gillespie BW, Greenbaum LA, Parekh RS, Hunley TE, Sperati CJ, Selewski DT, Kidd J, Chishti A, Reidy K, Mottl AK, Gipson DS, Srivastava T, Twombley KE. Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network. Am J Kidney Dis. 2023 06; 81(6):695-706.e1.
    View in: PubMed
    Score: 0.023
  33. Mariani LH, Eddy S, AlAkwaa FM, McCown PJ, Harder JL, Nair V, Eichinger F, Martini S, Ademola AD, Boima V, Reich HN, El Saghir J, Godfrey B, Ju W, Tanner EC, Vega-Warner V, Wys NL, Adler SG, Appel GB, Athavale A, Atkinson MA, Bagnasco SM, Barisoni L, Brown E, Cattran DC, Coppock GM, Dell KM, Derebail VK, Fervenza FC, Fornoni A, Gadegbeku CA, Gibson KL, Greenbaum LA, Hingorani SR, Hladunewich MA, Hodgin JB, Hogan MC, Holzman LB, Jefferson JA, Kaskel FJ, Kopp JB, Lafayette RA, Lemley KV, Lieske JC, Lin JJ, Menon R, Meyers KE, Nachman PH, Nast CC, O'Shaughnessy MM, Otto EA, Reidy KJ, Sambandam KK, Sedor JR, Sethna CB, Singer P, Srivastava T, Tran CL, Tuttle KR, Vento SM, Wang CS, Ojo AO, Adu D, Gipson DS, Trachtman H, Kretzler M. Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis. Kidney Int. 2023 03; 103(3):565-579.
    View in: PubMed
    Score: 0.023
  34. Ashrafzadeh-Kian SL, Ito N, Srivastava T, Garg U, Kato H, Algeciras-Schimnich A, Bornhorst JA. The effect of burosumab on intact and C-terminal FGF23 measurements. Clin Endocrinol (Oxf). 2023 08; 99(2):152-157.
    View in: PubMed
    Score: 0.023
  35. Gipson DS, Troost JP, Spino C, Attalla S, Tarnoff J, Massengill S, Lafayette R, Vega-Warner V, Adler S, Gipson P, Elliott M, Kaskel F, Fermin D, Moxey-Mims M, Fine RN, Brown EJ, Reidy K, Tuttle K, Gibson K, Lemley KV, Greenbaum LA, Atkinson MA, Hingorani S, Srivastava T, Sethna CB, Meyers K, Tran C, Dell KM, Wang CS, Yee JL, Sampson MG, Gbadegesin R, Lin JJ, Brady T, Rheault M, Trachtman H. Comparing Kidney Health Outcomes in Children, Adolescents, and Adults With Focal Segmental Glomerulosclerosis. JAMA Netw Open. 2022 08 01; 5(8):e2228701.
    View in: PubMed
    Score: 0.022
  36. Srivastava T, Alon US. Stage I vitamin D-deficiency rickets mimicking pseudohypoparathyroidism type II. Clin Pediatr (Phila). 2002 May; 41(4):263-8.
    View in: PubMed
    Score: 0.022
  37. Srivastava T, O'Neill JP, Dasouki M, Simckes AM. Childhood hyperuricemia and acute renal failure resulting from a missense mutation in the HPRT gene. Am J Med Genet. 2002 Mar 15; 108(3):219-22.
    View in: PubMed
    Score: 0.022
  38. Srivastava T, Alon US. Pneumonia-associated acute glomerulonephritis. Clin Nephrol. 2002 Mar; 57(3):175-82.
    View in: PubMed
    Score: 0.022
  39. Srivastava T, Whiting JM, Garola RE, Dasouki MJ, Ruotsalainen V, Tryggvason K, Hamed R, Alon US. Podocyte proteins in Galloway-Mowat syndrome. Pediatr Nephrol. 2001 Dec; 16(12):1022-9.
    View in: PubMed
    Score: 0.021
  40. Wang CS, Troost JP, Wang Y, Greenbaum LA, Gibson K, Trachtman H, Srivastava T, Reidy K, Kaskel F, Sethna CB, Meyers K, Dell KM, Tran CL, Hingorani S, Lemley KV, Lin JJ, Gipson DS. Determinants of medication adherence in childhood nephrotic syndrome and associations of adherence with clinical outcomes. Pediatr Nephrol. 2022 07; 37(7):1585-1595.
    View in: PubMed
    Score: 0.021
  41. Muff-Luett M, Sanderson KR, Engen RM, Zahr RS, Wenderfer SE, Tran CL, Sharma S, Cai Y, Ingraham S, Winnicki E, Weaver DJ, Hunley TE, Kiessling SG, Seamon M, Woroniecki R, Miyashita Y, Xiao N, Omoloja AA, Kizilbash SJ, Mansuri A, Kallash M, Yu Y, Sherman AK, Srivastava T, Nester CM. Eculizumab exposure in children and young adults: indications, practice patterns, and outcomes-a Pediatric Nephrology Research Consortium study. Pediatr Nephrol. 2021 08; 36(8):2349-2360.
    View in: PubMed
    Score: 0.020
  42. Shah PP, Brady TM, Meyers KEC, O'Shaughnessy MM, Gibson KL, Srivastava T, Zee J, Cattran D, Tuttle KR, Gadegbeku C, Glenn D, Derebail V, Smith A, Wang CS, Gillespie BW, Bitzer M, Sethna CB. Association of Obesity with Cardiovascular Risk Factors and Kidney Disease Outcomes in Primary Proteinuric Glomerulopathies. Nephron. 2021; 145(3):245-255.
    View in: PubMed
    Score: 0.020
  43. Zee J, McNulty MT, Hodgin JB, Zhdanova O, Hingorani S, Jefferson JA, Gibson KL, Trachtman H, Fornoni A, Dell KM, Reich HN, Bagnasco S, Greenbaum LA, Lafayette RA, Gipson DS, Brown E, Kretzler M, Appel G, Sambandam KK, Tuttle KR, Chen D, Atkinson MA, Hogan MC, Kaskel FJ, Meyers KE, O'Toole J, Srivastava T, Sethna CB, Hladunewich MA, Lin JJ, Nast CC, Derebail VK, Patel J, Vento S, Holzman LB, Athavale AM, Adler SG, Lemley KV, Lieske JC, Hogan JJ, Gadegbeku CA, Fervenza FC, Wang CS, Matar RB, Singer P, Kopp JB, Barisoni L, Sampson MG. APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis. Pediatr Nephrol. 2021 09; 36(9):2747-2757.
    View in: PubMed
    Score: 0.020
  44. Srivastava T, Garola RE, Whiting JM, Alon US. Synaptopodin expression in idiopathic nephrotic syndrome of childhood. Kidney Int. 2001 Jan; 59(1):118-25.
    View in: PubMed
    Score: 0.020
  45. Charlton JR, Tan W, Daouk G, Teot L, Rosen S, Bennett KM, Cwiek A, Nam S, Emma F, Jouret F, Oliveira JP, Tranebj?rg L, Frykholm C, Mane S, Hildebrandt F, Srivastava T, Storm T, Christensen EI, Nielsen R. Beyond the tubule: pathological variants of LRP2, encoding the megalin receptor, result in glomerular loss and early progressive chronic kidney disease. Am J Physiol Renal Physiol. 2020 12 01; 319(6):F988-F999.
    View in: PubMed
    Score: 0.020
  46. Srivastava T, Chadha V, Taboada EM, Alon US. C1q nephropathy presenting as rapidly progressive crescentic glomerulonephritis. Pediatr Nephrol. 2000 Sep; 14(10-11):976-9.
    View in: PubMed
    Score: 0.019
  47. Srivastava T, Alon US. Bisphosphonates: from grandparents to grandchildren. Clin Pediatr (Phila). 1999 Dec; 38(12):687-702.
    View in: PubMed
    Score: 0.018
  48. Sebestyen VanSickle J, Srivastava T, Garg U, Rezaiekhaligh MH, Alon US. Comparing directly measured versus mathematically calculated free serum 25-hydroxy vitamin D level in children. J Bone Miner Metab. 2020 Mar; 38(2):271-274.
    View in: PubMed
    Score: 0.018
  49. Srivastava T, Zwick DL, Rothberg PG, Warady BA. Posttransplant lymphoproliferative disorder in pediatric renal transplantation. Pediatr Nephrol. 1999 Nov; 13(9):748-54.
    View in: PubMed
    Score: 0.018
  50. Srivastava T, Garola RE, Hellerstein S. Autosomal dominant inheritance of multicystic dysplastic kidney. Pediatr Nephrol. 1999 Aug; 13(6):481-3.
    View in: PubMed
    Score: 0.018
  51. Srivastava T, Garola RE, Simckes AM. Clinical quiz. Right ureteric fungal bezoar causing urinary obstruction. Pediatr Nephrol. 1999 Aug; 13(6):549-51.
    View in: PubMed
    Score: 0.018
  52. Zahr RS, Yee ME, Weaver J, Twombley K, Matar RB, Aviles D, Sreedharan R, Rheault MN, Malatesta-Muncher R, Stone H, Srivastava T, Kapur G, Baddi P, Volovelsky O, Pelletier J, Gbadegesin R, Seeherunvong W, Patel HP, Greenbaum LA. Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol. 2019 08; 34(8):1435-1445.
    View in: PubMed
    Score: 0.018
  53. Canetta PA, Troost JP, Mahoney S, Kogon AJ, Carlozzi N, Bartosh SM, Cai Y, Davis TK, Fernandez H, Fornoni A, Gbadegesin RA, Herreshoff E, Mahan JD, Nachman PH, Selewski DT, Sethna CB, Srivastava T, Tuttle KR, Wang CS, Falk RJ, Gharavi AG, Gillespie BW, Greenbaum LA, Holzman LB, Kretzler M, Robinson BM, Smoyer WE, Guay-Woodford LM, Reeve B, Gipson DS. Health-related quality of life in glomerular disease. Kidney Int. 2019 05; 95(5):1209-1224.
    View in: PubMed
    Score: 0.018
  54. Srivastava T, Simon SD, Alon US. High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood. Pediatr Nephrol. 1999 Jan; 13(1):13-8.
    View in: PubMed
    Score: 0.017
  55. Wang CS, Travers C, McCracken C, Leong T, Gbadegesin R, Quiroga A, Benfield MR, Hidalgo G, Srivastava T, Lo M, Yadin O, Mathias R, Araya CE, Khalid M, Orjuela A, Zaritsky J, Al-Akash S, Kamel M, Greenbaum LA. Adrenocorticotropic Hormone for Childhood Nephrotic Syndrome: The ATLANTIS Randomized Trial. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1859-1865.
    View in: PubMed
    Score: 0.017
  56. Trachtman H, Nelson P, Adler S, Campbell KN, Chaudhuri A, Derebail VK, Gambaro G, Gesualdo L, Gipson DS, Hogan J, Lieberman K, Marder B, Meyers KE, Mustafa E, Radhakrishnan J, Srivastava T, Stepanians M, Tesar V, Zhdanova O, Komers R. DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS. J Am Soc Nephrol. 2018 11; 29(11):2745-2754.
    View in: PubMed
    Score: 0.017
  57. Pelletier JH, Kumar KR, Engen R, Bensimhon A, Varner JD, Rheault MN, Srivastava T, Straatmann C, Silva C, Davis TK, Wenderfer SE, Gibson K, Selewski D, Barcia J, Weng P, Licht C, Jawa N, Kallash M, Foreman JW, Wigfall DR, Chua AN, Chambers E, Hornik CP, Brewer ED, Nagaraj SK, Greenbaum LA, Gbadegesin RA. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings. Pediatr Nephrol. 2018 10; 33(10):1773-1780.
    View in: PubMed
    Score: 0.017
  58. VanSickle JS, Srivastava T, Alon US. Use of calcimimetics in children with normal kidney function. Pediatr Nephrol. 2019 03; 34(3):413-422.
    View in: PubMed
    Score: 0.016
  59. Adeyemo A, Esezobor C, Solarin A, Abeyagunawardena A, Kari JA, El Desoky S, Greenbaum LA, Kamel M, Kallash M, Silva C, Young A, Hunley TE, de Jesus-Gonzalez N, Srivastava T, Gbadegesin R. HLA-DQA1 and APOL1 as Risk Loci for Childhood-Onset Steroid-Sensitive and Steroid-Resistant Nephrotic Syndrome. Am J Kidney Dis. 2018 03; 71(3):399-406.
    View in: PubMed
    Score: 0.016
  60. Savin VJ, Sharma M, Zhou J, Genochi D, Sharma R, Srivastava T, Ilahe A, Budhiraja P, Gupta A, McCarthy ET. Multiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor. Biomed Res Int. 2017; 2017:6232616.
    View in: PubMed
    Score: 0.016
  61. Sethna CB, Meyers KEC, Mariani LH, Psoter KJ, Gadegbeku CA, Gibson KL, Srivastava T, Kretzler M, Brady TM. Blood Pressure and Visit-to-Visit Blood Pressure Variability Among Individuals With Primary Proteinuric Glomerulopathies. Hypertension. 2017 08; 70(2):315-323.
    View in: PubMed
    Score: 0.016
  62. Trachtman H, Vento S, Herreshoff E, Radeva M, Gassman J, Stein DT, Savin VJ, Sharma M, Reiser J, Wei C, Somers M, Srivastava T, Gipson DS. Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group. BMC Nephrol. 2015 Jul 22; 16:111.
    View in: PubMed
    Score: 0.014
  63. Savin VJ, Sharma M, Zhou J, Gennochi D, Fields T, Sharma R, McCarthy ET, Srivastava T, Domen J, Tormo A, Gauchat JF. Renal and Hematological Effects of CLCF-1, a B-Cell-Stimulating Cytokine of the IL-6 Family. J Immunol Res. 2015; 2015:714964.
    View in: PubMed
    Score: 0.014
  64. Sharma M, Zhou J, Gauchat JF, Sharma R, McCarthy ET, Srivastava T, Savin VJ. Janus kinase 2/signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier. Transl Res. 2015 Oct; 166(4):384-98.
    View in: PubMed
    Score: 0.013
  65. Gbadegesin RA, Adeyemo A, Webb NJ, Greenbaum LA, Abeyagunawardena A, Thalgahagoda S, Kale A, Gipson D, Srivastava T, Lin JJ, Chand D, Hunley TE, Brophy PD, Bagga A, Sinha A, Rheault MN, Ghali J, Nicholls K, Abraham E, Janjua HS, Omoloja A, Barletta GM, Cai Y, Milford DD, O'Brien C, Awan A, Belostotsky V, Smoyer WE, Homstad A, Hall G, Wu G, Nagaraj S, Wigfall D, Foreman J, Winn MP. HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome. J Am Soc Nephrol. 2015 Jul; 26(7):1701-10.
    View in: PubMed
    Score: 0.013
  66. Straatmann C, Ayoob R, Gbadegesin R, Gibson K, Rheault MN, Srivastava T, Tran CL, Gipson DS, Greenbaum LA, Smoyer WE, Vehaskari VM. Treatment outcome of late steroid-resistant nephrotic syndrome: a study by the Midwest Pediatric Nephrology Consortium. Pediatr Nephrol. 2013 Aug; 28(8):1235-41.
    View in: PubMed
    Score: 0.012
  67. Penido MG, Srivastava T, Alon US. Pediatric primary urolithiasis: 12-year experience at a Midwestern Children's Hospital. J Urol. 2013 Apr; 189(4):1493-7.
    View in: PubMed
    Score: 0.011
  68. Hogg RJ, Friedman A, Greene T, Radeva M, Budisavljevic MN, Gassman J, Gipson DS, Jefferson JA, John EG, Kaskel FJ, Moudgil A, Moxey-Mims M, Ortiz LA, Schelling JR, Schnaper W, Srivastava T, Trachtman H, Vehaskari VM, Wong C, Woronieki RP, Van Why SK, Zolotnitskaya A. Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS. Clin J Am Soc Nephrol. 2013 Feb; 8(2):211-8.
    View in: PubMed
    Score: 0.011
  69. Sebestyen JF, Srivastava T, Alon US. Bisphosphonates use in children. Clin Pediatr (Phila). 2012 Nov; 51(11):1011-24.
    View in: PubMed
    Score: 0.011
  70. Winston MJ, Srivastava T, Jarka D, Alon US. Bisphosphonates for pain management in children with benign cartilage tumors. Clin J Pain. 2012 Mar-Apr; 28(3):268-72.
    View in: PubMed
    Score: 0.011
  71. Goel SC, Tuli SM, Singh HP, Sharma SV, Saraf SK, Srivastava TP. Allogenic decalbone in the repair of benign cystic lesions of bone. Int Orthop. 1992; 16(2):176-9.
    View in: PubMed
    Score: 0.011
  72. Malloy PJ, Wang J, Srivastava T, Feldman D. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia resulting from a novel missense mutation in the DNA-binding domain of the vitamin D receptor. Mol Genet Metab. 2010 Jan; 99(1):72-9.
    View in: PubMed
    Score: 0.009
  73. Auron A, Tal L, Srivastava T, Alon US. Reversal of hypercalcemic acute kidney injury by treatment with intravenous bisphosphonates. Pediatr Nephrol. 2009 Mar; 24(3):613-7.
    View in: PubMed
    Score: 0.009
  74. Auron A, Warady BA, Simon S, Blowey DL, Srivastava T, Musharaf G, Alon US. Use of the multipurpose drainage catheter for the provision of acute peritoneal dialysis in infants and children. Am J Kidney Dis. 2007 May; 49(5):650-5.
    View in: PubMed
    Score: 0.008
  75. Waterhouse KM, Auron A, Srivastava T, Haney C, Alon US. Sustained beneficial effect of intravenous bisphosphonates after their discontinuation in children. Pediatr Nephrol. 2007 Feb; 22(2):282-7.
    View in: PubMed
    Score: 0.007
  76. Tuli SM, Srivastava TP, Sharma SV, Goel SC, Gupta D, Khanna S. The bridging of large osteoperiosteal gaps using 'Decalbone'. Int Orthop. 1988; 12(2):119-24.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.